Literature DB >> 20207821

Lymphangiogenesis-independent resolution of experimental edema.

Emily L Ongstad1, Echoe M Bouta, Jaclynn E Roberts, Joseph S Uzarski, Sara E Gibbs, Michael S Sabel, Vincent M Cimmino, Melissa A Roberts, Jeremy Goldman.   

Abstract

Vascular endothelial growth factor (VEGF)-C is necessary for lymphangiogenesis, and excess VEGF-C has been shown to be ameliorative for edema produced by lymphatic obstruction in experimental models. However, it has recently been shown that edema can resolve in the mouse tail even in the complete absence of capillary lymphangiogenesis when distal lymph fluid crosses the regenerating wound site interstitially. This finding has raised questions about the action of VEGF-C/VEGF receptor (VEGFR) signaling during the resolution of experimental edema. Here, the roles of VEGFR-2 and VEGFR-3 signaling in edema resolution were explored. It was found that edema resolved following neutralization of either VEGFR-2 or VEGFR-3 in the mouse tail skin, which inhibited lymphangiogenesis. Neutralization of either VEGFR-2 or VEGFR-3 reduced angiogenesis at the site of obstruction at day 10 (9.2 +/- 1.2% and 11.5 +/- 1.0% blood capillary coverage, respectively) relative to controls (14.3 +/- 1.5% blood capillary coverage). Combined VEGFR-2/-3 neutralization more strongly inhibited angiogenesis (6.9 +/- 1.5% blood capillary coverage), leading to a reduced wound repair of the lymphatic obstruction and extended edema in the tail skin. In contrast, improved tissue repair of the obstruction site increased edema resolution. Macrophages in the swollen tissue were excluded as contributing factors in the VEGFR-dependent extended edema. These results support a role for VEGFR-2/-3-combined signaling in the resolution of experimental edema that is lymphangiogenesis independent.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20207821      PMCID: PMC2904140          DOI: 10.1152/ajpheart.00008.2010

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  55 in total

1.  Interstitial flow as a guide for lymphangiogenesis.

Authors:  Kendrick C Boardman; Melody A Swartz
Journal:  Circ Res       Date:  2003-03-06       Impact factor: 17.367

2.  Subcutaneous interstitial fluid pressure and arm volume in lymphoedema.

Authors:  D O Bates; J R Levick; P S Mortimer
Journal:  Int J Microcirc Clin Exp       Date:  1992-11

3.  Proteolytic processing regulates receptor specificity and activity of VEGF-C.

Authors:  V Joukov; T Sorsa; V Kumar; M Jeltsch; L Claesson-Welsh; Y Cao; O Saksela; N Kalkkinen; K Alitalo
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

4.  Starling pressures in the human arm and their alteration in postmastectomy oedema.

Authors:  D O Bates; J R Levick; P S Mortimer
Journal:  J Physiol       Date:  1994-06-01       Impact factor: 5.182

5.  F4/80, a monoclonal antibody directed specifically against the mouse macrophage.

Authors:  J M Austyn; S Gordon
Journal:  Eur J Immunol       Date:  1981-10       Impact factor: 5.532

6.  Hyperplasia of lymphatic vessels in VEGF-C transgenic mice.

Authors:  M Jeltsch; A Kaipainen; V Joukov; X Meng; M Lakso; H Rauvala; M Swartz; D Fukumura; R K Jain; K Alitalo
Journal:  Science       Date:  1997-05-30       Impact factor: 47.728

7.  Peritumor lymphatics induced by vascular endothelial growth factor-C exhibit abnormal function.

Authors:  Naohide Isaka; Timothy P Padera; Jeroen Hagendoorn; Dai Fukumura; Rakesh K Jain
Journal:  Cancer Res       Date:  2004-07-01       Impact factor: 12.701

8.  Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.

Authors:  A Kaipainen; J Korhonen; T Mustonen; V W van Hinsbergh; G H Fang; D Dumont; M Breitman; K Alitalo
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

9.  A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.

Authors:  V Joukov; K Pajusola; A Kaipainen; D Chilov; I Lahtinen; E Kukk; O Saksela; N Kalkkinen; K Alitalo
Journal:  EMBO J       Date:  1996-01-15       Impact factor: 11.598

10.  VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development.

Authors:  E Kukk; A Lymboussaki; S Taira; A Kaipainen; M Jeltsch; V Joukov; K Alitalo
Journal:  Development       Date:  1996-12       Impact factor: 6.868

View more
  9 in total

1.  Biomaterial guides for lymphatic endothelial cell alignment and migration.

Authors:  Echoe M Bouta; Connor W McCarthy; Alexander Keim; Han Bing Wang; Ryan J Gilbert; Jeremy Goldman
Journal:  Acta Biomater       Date:  2010-10-23       Impact factor: 8.947

2.  Functional recovery of fluid drainage precedes lymphangiogenesis in acute murine foreleg lymphedema.

Authors:  Uziel Mendez; Emily M Brown; Emily L Ongstad; Justin R Slis; Jeremy Goldman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

3.  Lymphatic function is regulated by a coordinated expression of lymphangiogenic and anti-lymphangiogenic cytokines.

Authors:  Jamie C Zampell; Tomer Avraham; Nicole Yoder; Nicholas Fort; Alan Yan; Evan S Weitman; Babak J Mehrara
Journal:  Am J Physiol Cell Physiol       Date:  2011-09-21       Impact factor: 4.249

4.  VEGFR-3 blocking deteriorates inflammation with impaired lymphatic function and different changes in lymphatic vessels in acute and chronic colitis.

Authors:  Xiao-Lei Wang; Jing Zhao; Li Qin; Jing-Li Cao
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

5.  Fibrosis worsens chronic lymphedema in rodent tissues.

Authors:  Laura L Lynch; Uziel Mendez; Anna B Waller; Amani A Gillette; Roger J Guillory; Jeremy Goldman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-03-13       Impact factor: 4.733

6.  Increased hyaluronan expression at distinct time points in acute lymphedema.

Authors:  Melissa A Roberts; Uziel Mendez; Ryan J Gilbert; Alexander P Keim; Jeremy Goldman
Journal:  Lymphat Res Biol       Date:  2012-09       Impact factor: 2.589

7.  The multicomponent medication lymphomyosot improves the outcome of experimental lymphedema.

Authors:  Alex P Keim; Justin R Slis; Uziel Mendez; Emily M Stroup; Yvonne Burmeister; Natalie Tsolaki; Oliver Gailing; Jeremy Goldman
Journal:  Lymphat Res Biol       Date:  2013-06-01       Impact factor: 2.589

8.  A chronic and latent lymphatic insufficiency follows recovery from acute lymphedema in the rat foreleg.

Authors:  Uziel Mendez; Emily M Stroup; Laura L Lynch; Anna B Waller; Jeremy Goldman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-31       Impact factor: 4.733

Review 9.  Regulation of Immune Function by the Lymphatic System in Lymphedema.

Authors:  Raghu P Kataru; Jung Eun Baik; Hyeung Ju Park; Itay Wiser; Sonia Rehal; Jin Yeon Shin; Babak J Mehrara
Journal:  Front Immunol       Date:  2019-03-18       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.